Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C16H19NO2.C4H4O4 |
| Molecular Weight | 373.3997 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)\C=C\C(O)=O.CN(C)CC(OC1=CC=CC=C1)OC2=CC=CC=C2
InChI
InChIKey=CSQUJXBMSDQIKM-WLHGVMLRSA-N
InChI=1S/C16H19NO2.C4H4O4/c1-17(2)13-16(18-14-9-5-3-6-10-14)19-15-11-7-4-8-12-15;5-3(6)1-2-4(7)8/h3-12,16H,13H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1+
| Molecular Formula | C4H4O4 |
| Molecular Weight | 116.0722 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
| Molecular Formula | C16H19NO2 |
| Molecular Weight | 257.3276 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2253668
After an overnight fast, ascending doses of 200, 500, 750 and 1000 mg of medifoxamine were taken orally
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:03:03 GMT 2025
by
admin
on
Mon Mar 31 18:03:03 GMT 2025
|
| Record UNII |
OAG6T7TVU2
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C034065
Created by
admin on Mon Mar 31 18:03:03 GMT 2025 , Edited by admin on Mon Mar 31 18:03:03 GMT 2025
|
PRIMARY | |||
|
6450232
Created by
admin on Mon Mar 31 18:03:03 GMT 2025 , Edited by admin on Mon Mar 31 18:03:03 GMT 2025
|
PRIMARY | |||
|
236781
Created by
admin on Mon Mar 31 18:03:03 GMT 2025 , Edited by admin on Mon Mar 31 18:03:03 GMT 2025
|
PRIMARY | RxNorm | ||
|
240-657-2
Created by
admin on Mon Mar 31 18:03:03 GMT 2025 , Edited by admin on Mon Mar 31 18:03:03 GMT 2025
|
PRIMARY | |||
|
m7131
Created by
admin on Mon Mar 31 18:03:03 GMT 2025 , Edited by admin on Mon Mar 31 18:03:03 GMT 2025
|
PRIMARY | Merck Index | ||
|
OAG6T7TVU2
Created by
admin on Mon Mar 31 18:03:03 GMT 2025 , Edited by admin on Mon Mar 31 18:03:03 GMT 2025
|
PRIMARY | |||
|
16604-45-8
Created by
admin on Mon Mar 31 18:03:03 GMT 2025 , Edited by admin on Mon Mar 31 18:03:03 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE | |||
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |